The impact of intravenous fat emulsion administration in acute lung injury

dc.contributor.authorLekka, M. E.en
dc.contributor.authorLiokatis, S.en
dc.contributor.authorNathanail, C.en
dc.contributor.authorGalani, V.en
dc.contributor.authorNakos, G.en
dc.date.accessioned2015-11-24T16:50:43Z
dc.date.available2015-11-24T16:50:43Z
dc.identifier.issn1073-449X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/9634
dc.rightsDefault Licence-
dc.subjectparenteral nutritionen
dc.subjectmedium-chain triglycericles/long-chain triglyceridesen
dc.subjectphospholipase a(2)en
dc.subjectplatelet-activating factor-acetylhydrolaseen
dc.subjectplatelet-activating factoren
dc.subjectrespiratory-distress-syndromeen
dc.subjectplatelet-activating-factoren
dc.subjectpulmonary surfactanten
dc.subjectgas-exchangeen
dc.subjectintralipid infusionen
dc.subjectphospholipases a(2)en
dc.subjectpermeabilityen
dc.subjectproteinsen
dc.subjectardsen
dc.subjectlysophosphatidylcholineen
dc.titleThe impact of intravenous fat emulsion administration in acute lung injuryen
heal.abstractThe aim of this study was to evaluate the effect of parenteral nutrition containing medium- and long-chain triglycerides on the function of the respiratory system and to investigate mechanisms involved in this process. We studied 13 patients with acute respiratory distress syndrome (ARDS), 8 receiving lipid and 5 placebo, and 6 without ARDS, receiving lipid. Bronchoalveolar lavage (BAL) was performed before and 1 hour after administration of lipid or placebo. In patients with ARDS, lipid administration resulted in deterioration of oxygenation (Pa-O2/Fi(O2): from 129 +/- 37 to 95 +/- 42), compliance of respiratory system (from 39.2 +/- 12 to 33.1 +/- 9.2 ml/cm H2O), and pulmonary vascular resistance (from 258 +/- 47 to 321 +/- 58 dyne.s.cm(-1)). In the BAL fluid of the same group, an increase in total protein and phospholipid concentrations, phospholipase activities, platelet-activating factor and neutrophils, as well as alterations in BAL lipid profile were observed. No significant changes were observed in the control or in the ARDS-Placebo groups. In conclusion, this study indicates that administration of medium- and long-chain triglycerides in patients with ARDS causes alterations in lung function and hemodynamics. Inflammatory cells, possibly activated by lipids, release phospholipase A(2) and platelet-activating factor, enhancing edema formation, inflammation, and surfactant alterations.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondary<Go to ISI>://000189249300019-
heal.identifier.secondaryhttp://ajrccm.atsjournals.org/content/169/5/638.full.pdf-
heal.journalNameAm J Respir Crit Care Meden
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2004-
heal.publisherAmerican Thoracic Societyen
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
Lekka-2004-The impact of intrav.pdf
Μέγεθος:
188.38 KB
Μορφότυπο:
Adobe Portable Document Format

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: